Trust Co. of Toledo NA OH decreased its holdings in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 2.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,622 shares of the company’s stock after selling 463 shares during the period. Trust Co. of Toledo NA OH’s holdings in Colgate-Palmolive were worth $1,602,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Price T Rowe Associates Inc. MD increased its position in Colgate-Palmolive by 18.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock worth $3,186,651,000 after purchasing an additional 5,269,140 shares during the period. Nuveen LLC acquired a new position in Colgate-Palmolive during the 1st quarter worth approximately $217,593,000. Goldman Sachs Group Inc. increased its position in Colgate-Palmolive by 34.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock worth $747,762,000 after purchasing an additional 2,045,191 shares during the period. Diamond Hill Capital Management Inc. increased its position in Colgate-Palmolive by 45.0% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company’s stock worth $521,250,000 after purchasing an additional 1,727,105 shares during the period. Finally, Alliancebernstein L.P. increased its position in Colgate-Palmolive by 60.5% during the 1st quarter. Alliancebernstein L.P. now owns 2,336,783 shares of the company’s stock worth $218,957,000 after purchasing an additional 880,527 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on CL shares. Citigroup lowered their price target on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a report on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $86.00 target price on Colgate-Palmolive in a research report on Friday. Bank of America decreased their target price on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday. UBS Group decreased their target price on Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday. Finally, The Goldman Sachs Group decreased their target price on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research report on Thursday, October 2nd. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $92.21.
Colgate-Palmolive Price Performance
Shares of NYSE:CL opened at $77.99 on Friday. The business’s fifty day moving average price is $82.56 and its two-hundred day moving average price is $87.91. The stock has a market cap of $63.03 billion, a PE ratio of 21.91, a price-to-earnings-growth ratio of 4.28 and a beta of 0.34. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. Colgate-Palmolive Company has a one year low of $77.09 and a one year high of $102.61.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion for the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive’s quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.91 EPS. On average, analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is 58.43%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- What is the Dow Jones Industrial Average (DJIA)?
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.